Objective: To review current concepts of physiopathology, diagnosis and treatment of diabetic ketoacidosis (DKA) in childhood, as well as preventive measures to avoid cerebral edema.
Introduction
Diabetic ketoacidosis (DKA) is a frequent cause of admission in emergency rooms or pediatric intensive care unit (PICU), and even nowadays it has high morbidity and mortality rates. After insulin was discovered and introduced in the treatment of DKA, it has been possible to reduce its mortality from 100% (early 20 th century) for the current 2-5%.
in infections. 2, 10 High doses of glucocorticoids, atypical antipsychotics, diazoxide and some immunosuppressive drugs have been reported as KDA precipitants in patients without previous diagnosis. 2 Other causes of KDA are pancreatitis and trauma. 9, 15 As a general rule, possible triggering factors should be assessed in all patients with KDA and only after they are discarded the irregular treatment should be considered as causal factor. In 2-10% of cases, it is not possible to identify the precipitating factor.
9,15

Physiopathology
Clinical manifestations and laboratory changes in DKA ( Figure 1 ) occur as a consequence of interactions of absolute or relative insulin deficiency and increased counter-regulatory hormones (glucagon, catecholamines, cortisol and growth hormone). Therefore, counter-regulatory hormones are usually increased in situations of infection and stress, which often precipitate DKA in diabetic patients, whereas hyperglycemia, dehydration, hyperosmolarity, electrolytic and acid-basic disorders perpetuate release of counter-regulatory hormones.
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Ketoacidosis
Insulin is an anabolic hormone, promoting synthesis and/or storage of carbohydrates, fats, proteins and nucleic acids. Insulin action allows energy generation through use of glucose by muscles, adipose tissue and liver cells. When insulin is absent, there is lipolysis with increased fatty acid mobilization for hepatic gluconeogenesis and release of ketone bodies. Excessive production of ketones exceeds the buffer capacity of organic alkalis, resulting in metabolic acidosis.
Consequently, according to acidosis intensity, DKA can be quantified into mild (pH 7.3-7.2), moderate (7.2-7.1) and severe (< 7.1). 1, 2, 9, 15 A characteristic of metabolic acidosis in DKA is increased anion gap (normally between 10 and 12), which is obtained by the following formula: anion gap = Na -(HCO 3 + Cl).
In DKA, ketosis is primarily caused by increase in β-hydroxybutyrate and acetoacetate. Beta-hydroxybutyrate is the ketone found in higher circulating levels during DKA, with a β-hydroxybutyrate:acetoacetate ratio of 3:1 during early disease stages. Ketonemia tests are generally performed qualitatively or semi-quantitatively in relation to acetoacetate. Considering that, during ketoacidosis correction, β-hydroxybutyrate is transformed into acetoacetate, ketonemia test can be positive for some time, even with proper treatment. Therefore, persistence of positive ketonemia does not necessarily mean that DKA treatment is being ineffective. 9 Anion gap could thus be used as an indirect indicator of ketone body levels, since reduction in anion gap value represents reduced ketone body levels, which represent treatment efficiency. Diabetic ketoacidosis in children -Piva JP et al.
Hyperglycemia
In case of insulin deficiency (or absence) associated with the action of counter-regulatory hormones, cells cannot capture and metabolize glucose, causing muscle and hepatic glycogenolysis and subsequent hyperglycemia. 9 Blood glucose levels higher than 180 mg/dL exceed the maximum capacity of glucose reabsorption in the proximal tubule, causing glycosuria and osmotic diuresis. Osmotic diuresis leads to polyuria with loss of free water and electrolytes, promoting polydipsia. In If adequate water ingestion is maintained, dehydration will be mild and blood glucose will stabilize between 300-400 mg/dL. In some cases, blood glucose can reach levels of up to 800 mg/dL, especially when there is severe dehydration with reduction in glomerular filtration rate. 9, 15, 16 Although hyperglycemia is the rule in DKA, there may be cases of DKA with normal blood glucose levels. This phenomenon occurs in patients partially treated with insulin and without receiving fluids with carbohydrates and/or in situations with long periods of vomiting and no ingestion of carbohydrates.
1,2,9,12,16
Dehydration
Osmotic diuresis associated with vomiting and insufficient ingestion causes dehydration of several degrees in DKA, while shock is a rare event in this situation. 1 As dehydration progresses, there is reduction in the intravascular volume and consequent progressive loss of glomerular filtration rate.
Reduction in glomerular filtration rate causes reduction in diuresis and glucose loss, resulting in worsening of hyperglycemia. Blood glucose levels close to 600 mg/dL indicate that glomerular filtration rate is reduced in approximately 25%, whereas glucose of 800 mg/dL suggests a 50% reduction in glomerular filtration rate, as a consequence of severe dehydration.
1,2,9,10
Hyperosmolarity
Plasma osmolarity can be estimated using the calculation [(Na + K) x2] + (blood glucose/18). It is easy to note that, with blood glucose at 180 mg/dL, contribution of glucose in plasma osmolarity will be minimal (around 10). However, in case of blood glucose increases to, for instance, 720 mg/dL, osmolarity impact caused by hyperglycemia will be 40. Under these circumstances, there is movement of free water from the intracellular to the extracellular space (intracellular dehydration). Maintenance of this hyperosmolar state stimulates cells' (especially neurons) production of substances with intracellular osmotic activity (idiogenic osmoles) to preserve intracellular water. In case of sudden fall in blood osmolarity (quick fall of blood glucose or reduction in plasma sodium), this will cause the shift of water into the intracellular space, favoring occurrence of cerebral edema. [14] [15] [16] It has been demonstrated that hypernatremia can be a protective factor of cerebral edema in patients with DKA.
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Electrolytic disorders
Polyuria caused by osmotic diuresis may induce dehydration with several degrees of associated electrolytic changes:
hyper-or hyponatremia, hypokalemia, hypophosphatemia and hypocalcemia.
Sodium
In DKA, there may be dilutional hyponatremia associated with increased osmolarity caused by hyperglycemia. A reduction in the blood sodium level of 1.6 mEq/L is estimated for each 100 mg/dL of glucose above the limit of 100 mg/dL. Nevertheless, even if this occurs, it should be stressed that total body potassium is reduced. Therefore, normal or reduced potassium dosage at the beginning of DKA indicates need of early replacement, since the treatment tends to reduce serum levels of this ion.
1,2,9,11
Calcium
As a result of acidosis correction during DKA treatment and improvement in glomerular filtration rate, there is a tendency to hypocalcemia. Use of phosphate in the treatment of patients with DKA is also associated with hypocalcemia. There is also tachypnea (hyperventilation to compensate metabolic acidosis), ketotic breath (sweetish odor due to ketosis) and fever (which can be associated with infectious, bacterial or viral process).
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DKA should be suspected in every patient who has depression of sensorium with or without clinical signs of acidosis;
capillary blood glucose screening and/or tests for ketonuria should always be performed in initial assessment. 
Correction of dehydration and electrolytic disorders
Volumetric replacement in DKA follows the same principles of other situations of dehydration or shock: an initial stage of rapid expansion (1-4 hours) followed by a slower stage of rehydration and replacement of losses (20) (21) (22) hours). 1,2,9,16 Some retrospective and multi-centered studies concluded that in DKA there is a strong association between cerebral edema and administration of large amounts of fluids. 13, 14 However, it should be stressed that those studies do not allow concluding that cerebral edema exclusively occurred due to excess of infused fluids or because it is a most severe group of patients, which requires more amount of volume replacement. As long as such doubt is not clarified, we have followed the current recommendations for volume replacement in patients with dehydration and/or shock: volume expansion in the early stage followed by a moderate maintenance during the late stage. peripheral accesses should be punctured, so that the volume calculated is replaced within predicted time.
DKA usually requires two to three volume expansions of 20 mL/kg with NSS until dehydration signs are reverted. This fast replacement with SS reestablishes blood volume and improves renal perfusion, which increases glomerular filtration, resulting in glucose-induced osmotic diuresis, with reduction in blood glucose and plasma osmolarity. 1, 9, 17 In the treatment of DKA, expansions with NSS, since it is isotonic in relation to plasma (NSS: Na = 154 mEq/L), promote higher increase in blood volume than the diluted solutions, causing a slower reduction in the osmolarity. 1, 9, 17 Therefore, even in situations of DKA in which initial serum sodium is higher than 150 mEq/L, hypotonic solutions are not used.
Rehydration stage (20-22 hours)
As soon as the signs of blood volume depletion (tachycar- Some authors suggest initial use of NaCl 0.45% (Na = 75 mEq/L) in cases in which serum sodium exceeds 150 mEq/L, or when calculated plasma osmolarity is higher than 340 mOsm/L. 12, 15 Due to the reasons described above, even in those cases, we prefer to maintain infusion of isotonic NSS until blood glucose is around 300 mg/dL, when 5 g of glucose should be added for each 100 mL. 1, 9, 16, 17 It is estimated that there is a potassium deficit of 4-6 mEq/kg in DKA, which is more evident after acidosis correction and due to insulin action (which promotes input of glucose and potassium into the cell). Oral diet should be started with the patient awake, without vomiting and with improved acidosis. Parenteral hydration solution should be maintained as along as continuous insulin is necessary.
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Insulin therapy
Administration of insulin promotes glucose input into the intracellular space, reverts catabolic status and suppresses lipolysis and ketogenesis, correcting blood glucose and acidosis. 1, 2, 10, 18, [22] [23] [24] Despite the fact that some authors recommend an infusion of a loading dose of regular insulin (0.1 IU/kg) in patients with DKA, we have chosen to directly start continuous infusion of 0.1 IU/kg/h of regular insulin diluted in NSS. 1, 2, 9, 11, 23 As previously mentioned, adequate replacement of blood volume induces improvement in renal perfusion, resulting in reduced blood glucose. If, associated with this fact, we administer a loading dose of regular insulin, we can induce a marked reduction in blood glucose and osmolarity (main factor associated with cerebral edema). 1, 9, 23 In our services, we use a dilution of regular insulin at 0.1 IU/mL (250 mL of SS adding 25 IU of regular insulin), which is infused at a speed of 1 mL/kg/h (0.1 IU/kg/h) using an infusion pump. Due to insulin adherence to plastic, we use the first 50 mL of the solution to wash the catheter. Acidosis and ketonemia are the main markers of insulin and glucose insufficiency in the cell metabolism during DKA.
Blood glucose correction is faster than acidosis correction.
Therefore, in patients who have major reduction in blood glucose, but who maintain positive acidosis and/or ketonemia, continuous insulin infusion should not be reduced. In these cases, it is necessary to increase glucose infusion, sometimes using 10% glucose. 
Cardiac arrhythmias
These are caused by electrolytic disorders (hypo-or hyperpotassemia, hypocalcemia, hypomagnesemia), and rarely occur in DKA.
7,9
Aspiration of gastric content
As major changes in the sensorium occur and many patients have recurrent vomiting, there may be pulmonary aspiration of gastric content. This complication should be prevented by careful supervision of patients at an adequate hospital setting.
Pulmonary edema
It is not a common complication. There is an increase in oxygen demand, and there may or may not be radiological changes compatible with pulmonary edema. Many factors can be involved: low oncotic pressure, increased pulmonary capillary permeability and neurogenic pulmonary edema. Treatment includes oxygen therapy, use of diuretics and ventilatory support when indicated.
9,27-29
Cerebral edema
It is practically restricted to the pediatric age group, with prevalence of 1-2% in children with DKA, being more prevalent in children 5 years and younger and in the first DKA diagnosis. It is a much feared complication of DKA, since it has mortality rate between 40-90%, whereas part of survivors will have sequelae. There is evidence that many patients with DKA have some degree of subclinical cerebral edema even before starting treatment. 3, 13, 14, 16, [30] [31] [32] [33] Clinical manifestations of cerebral edema are usually sudden, and there may be fast progression to brain herniation, even when clinical status is recognized and aggressively treated. 31 Cerebral edema usually occurs within 4-12 hours after beginning treatment and at the moment acidosis, dehydration and hyperglycemia, as well as the patient's general status, are improving. Initial signs and symptoms are headache and reduced level of consciousness, which quickly progress to deterioration of sensorium, dilated pupils, bradycardia and respiratory arrest. In some cases, it can be preceded by a period of change in behavior associated or not with Treatment of cerebral edema can be performed using infusions of mannitol 0.25-0.5 g/kg/day at every 2-4 hours, or using 3% hypertonic saline solution (5-10 mL/kg/every 30 min), maintaining plasma sodium between 150-160 mEq/L.
In cases with early diagnosis, before occurrence of changes in pupil and heart rate, mannitol often promotes significant improvement, and intubation and ventilatory support are not 
Prevention
Despite improvement in diagnostic and therapeutic resources, there has been no reduction in mortality due to DKA over the past 2 decades. [1] [2] [3] 13, 14, 17 Therefore, the main objective of managing patients with insulin-dependent DM should de prevention of DKA episodes through a high suspicion index with rigorous monitoring of symptoms. DKA. 1 It is also important to stress that whenever a diagnosis of DM is established, we should also characterize whether DM is insulin-dependent or not. In children and adolescents, at first, all cases are insulin-dependent. In this situation, all patients with DM should be treated from the start using insulin therapy. Use of oral hypoglycemic agents is not indicated, since they are dependent upon existence of pancreatic insulin secretion to be effective. Unfortunately, there are still cases of patients with recently diagnosed DM that progress to DKA when oral hypoglycemic agents are used. In these cases, DKA could be prevented by correct diagnostic and therapeutic guidance of insulin-dependent DM.
